DarioHealth Announces Independent Aon Analysis that Supports Estimated 2.5%-7.2% In-Year Reduction in Total Healthcare Costs
A component study of the independent review by Aon found $5,077 in annual savings and 23.5% fewer inpatient discharges per Dario user with type 2 diabetes versus matched non-users Evaluation of 17 studies estimates $3.8 million to $10.8 million in annual savings for a 20,000-life...
Covered in this story
What has happened since
- Aon plc is up 8.3% since this was published, 14 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Aon plc
- Piper Sandler: $326 → $349 by Sep 2027 · Neutral via Investing.com
- Mizuho: $326 → $398 by Sep 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $AON yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Aon plc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.